dc.contributor.author | Haslerud, Torjan Magne | en_US |
dc.contributor.author | Brauckhoff, Katrin | en_US |
dc.contributor.author | Reisæter, Lars Anders Rokne | en_US |
dc.contributor.author | Lein, Regina Küfner | en_US |
dc.contributor.author | Heinecke, A. | en_US |
dc.contributor.author | Varhaug, Jan Erik | en_US |
dc.contributor.author | Biermann, Martin | en_US |
dc.date.accessioned | 2016-01-05T10:11:02Z | |
dc.date.available | 2016-01-05T10:11:02Z | |
dc.date.issued | 2015-07-09 | |
dc.Published | Acta Radiologica 2015, 9(135) | eng |
dc.identifier.issn | 0284-1851 | |
dc.identifier.uri | https://hdl.handle.net/1956/10865 | |
dc.description.abstract | Background Positron emission tomography (PET) with fluor-18-deoxy-glucose (FDG) is widely used for diagnosing recurrent or metastatic disease in patients with differentiated thyroid cancer (DTC). Purpose To assess the diagnostic accuracy of FDG-PET for DTC in patients after ablative therapy. Material and Methods A systematic search was conducted in Medline/PubMed, EMBASE, Cochrane Library, Web of Science, and Open Grey looking for all English-language original articles on the performance of FDG-PET in series of at least 20 patients with DTC having undergone ablative therapy including total thyroidectomy. Diagnostic performance measures were pooled using Reitsma’s bivariate model. Results Thirty-four publications between 1996 and 2014 met the inclusion criteria. Pooled sensitivity and specificity were 79.4% (95% confidence interval [CI], 73.9–84.1) and 79.4% (95% CI, 71.2–85.4), respectively, with an area under the curve of 0.858. Conclusion F18-FDG-PET is a useful method for detecting recurrent DTC in patients having undergone ablative therapy. | en_US |
dc.language.iso | eng | eng |
dc.publisher | SAGE | eng |
dc.rights | Attribution CC BY | eng |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0 | eng |
dc.subject | Head/neck | eng |
dc.subject | PET-CT | eng |
dc.subject | neoplasms | eng |
dc.subject | thyroid | eng |
dc.title | F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis | en_US |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.date.updated | 2015-12-22T10:32:32Z | |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright The Foundation Acta Radiologica 2015 | |
dc.identifier.doi | https://doi.org/10.1177/0284185115594645 | |
dc.identifier.cristin | 1254044 | |
dc.subject.nsi | VDP::Medisinske Fag: 700 | en_US |